Related references
Note: Only part of the references are listed.Integrin α7 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma
Zhiyong Lv et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
A centralized communication network: Recent insights into the role of the cancer associated fibroblast in the development of drug resistance in tumors
Andrew Leask
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)
Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and sternness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma
Jun-Chen Ge et al.
CELLULAR SIGNALLING (2020)
Integrin α6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells
Andreas Herrmann et al.
ONCOGENE (2020)
Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation
Qing Ji et al.
NATURE COMMUNICATIONS (2020)
Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1
Wenjing Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells
Jingshu Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
AhR ligand aminoflavone suppresses α6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells
Petreena S. Campbell et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance
Jonathan Cooper et al.
CANCER CELL (2019)
Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling
Siyang Wen et al.
CANCER LETTERS (2019)
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer
Qinglei Gao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Alpha6-Integrin Regulates FGFR1 Expression through the ZEB1/YAP1 Transcription Complex in Glioblastoma Stem Cells Resulting in Enhanced Proliferation and Stemness
Aline Kowalski-Chauvel et al.
CANCERS (2019)
Integrins and Their Role in Immune Cell Adhesion
Michael L. Dustin
CELL (2019)
The Extracellular Matrix Modulates the Metastatic Journey
FuiBoon Kai et al.
DEVELOPMENTAL CELL (2019)
Exosome-Mediated Metastasis: Communication from a Distance
Inbal Wortzel et al.
DEVELOPMENTAL CELL (2019)
Integrin α9 depletion promotes β-catenin degradation to suppress triple-negative breast cancer tumor growth and metastasis
Zhishan Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia
Sofiane Berrazouane et al.
CELL DEATH & DISEASE (2019)
Role of Integrins in Resistance to Therapies Targeting Growth Factor Receptors in Cancer
Elisabete Cruz da Silva et al.
CANCERS (2019)
Integrins, CAFs and Mechanical Forces in the Progression of Cancer
Imjoo Jang et al.
CANCERS (2019)
Collagen facilitates the colorectal cancer sternness and metastasis through an integrin/PI3K/AKT/Snail signaling pathway
Xiangbin Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
High-affinity peptide ligand LXY30 for targeting 31 integrin in non-small cell lung cancer
Wenwu Xiao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
β8 Integrin Mediates Pancreatic Cancer Cell Radiochemoresistance
Sha Jin et al.
MOLECULAR CANCER RESEARCH (2019)
Novel Integrin αvβ3-Specific Ligand for the Sensitive Diagnosis of Glioblastoma
Lei Zhang et al.
MOLECULAR PHARMACEUTICS (2019)
Integrins as biomechanical sensors of the microenvironment
Jenny Z. Kechagia et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
α11β1 Integrin is Induced in a Subset of Cancer-Associated Fibroblasts in Desmoplastic Tumor Stroma and Mediates In Vitro Cell Migration
Cedric Zeltz et al.
CANCERS (2019)
Stromal integrin α11 regulates PDGFRβ signaling and promotes breast cancer progression
Irina Primac et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Role of integrin β1 as a biomarker of sternness in head and neck squamous cell carcinoma
Jung Hwa Moon et al.
ORAL ONCOLOGY (2019)
Visualisation of interstitial lung disease by molecular imaging of integrin αvβ3 and somatostatin receptor 2
Janine Schniering et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy
Ping-Hsiu Wu et al.
CANCERS (2019)
Blockade of integrin 3 signals to reverse the stem-like phenotype and drug resistance in melanoma
Xiaoxia Zhu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Laminin 2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via integrin 3-dependent uptake by lymphatic endothelial cells
Ssu-Han Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Reciprocal regulation of integrin 4 and KLF4 promotes gliomagenesis through maintaining cancer stem cell traits
Binbin Ma et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Hypoxia-driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating forkhead box protein M1
Junyu Cao et al.
MOLECULAR ONCOLOGY (2019)
Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts
Jing Kong et al.
MOLECULAR CANCER (2019)
The Interaction between Laminin-332 and alpha 3 beta 1 Integrin Determines Differentiation and Maintenance of CAFs, and Supports Invasion of Pancreatic Duct Adenocarcinoma Cells
Ana C. Martins Cavaco et al.
CANCERS (2019)
Absence of integrin 31 promotesthe progression of HER2-driven breast cancer in vivo
Veronika Ramovs et al.
BREAST CANCER RESEARCH (2019)
Targeted therapeutic options and future perspectives for HER2-positive breast cancer
Jiani Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
Min Yuan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Evaluation of Serum Integrin αvβ3 & Vitronectin in the Early Diagnosis of Breast Cancer
Abdullah F. Radwan et al.
CLINICAL LABORATORY (2019)
RGD cadherins and α2β1 integrin in cancer metastasis: A dangerous liaison
J. Ignacio Casal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors
Colin D. Weekes et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer: A Phase I Study
Carole Massabeau et al.
CLINICAL LUNG CANCER (2018)
Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma
Ruixia Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Comparison of the RGD Motif-Containing αvβ6 Integrin-Binding Peptides SFLAP3 and SFITGv6 for Diagnostic Application in HNSCC
Saskia Roesch et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells
Shaocong Wu et al.
MOLECULAR CANCER (2018)
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
Tian Fang et al.
NATURE COMMUNICATIONS (2018)
Integrin α9 Suppresses Hepatocellular Carcinoma Metastasis by Rho GTPase Signaling
Yan-Li Zhang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Integrin β1 promotes gemcitabine resistance in pancreatic cancer through Cdc42 activation of PI3K p110β signaling
Dejun Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
The soluble nectin-4 ecto-domain promotes breast cancer induced angiogenesis via endothelial Integrin-β4
Sumit Siddharth et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Integrin αvβ6 plays a bi-directional regulation role between colon cancer cells and cancer-associated fibroblasts
Cheng Peng et al.
BIOSCIENCE REPORTS (2018)
An RGD small-molecule integrin antagonist induces detachment-mediated anoikis in glioma cancer stem cells
Mayra Paolillo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels
David Novo et al.
NATURE COMMUNICATIONS (2018)
Tenascin-C Promotes Tumor Cell Migration and Metastasis through Integrin α9β1-Mediated YAP Inhibition
Zhen Sun et al.
CANCER RESEARCH (2018)
Glycosylation and Integrin Regulation in Cancer
Grazia Marsico et al.
TRENDS IN CANCER (2018)
Targeted chemotherapy for subcutaneous and orthotopic non-small cell lung tumors with cyclic RGD-functionalized and disulfide-crosslinked polymersomal doxorubicin
Yan Zou et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Every step of the way: integrins in cancer progression and metastasis
Hellyeh Hamidi et al.
NATURE REVIEWS CANCER (2018)
Co-targeting of EGF receptor and neuropilin-1 overcomes cetuximab resistance in pancreatic ductal adenocarcinoma with integrin β1-drivenSrc-Akt bypass signaling
Y-J Kim et al.
ONCOGENE (2017)
Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin
Begum Erdogan et al.
JOURNAL OF CELL BIOLOGY (2017)
Cancer-associated fibroblasts lead tumor invasion through integrin-β3-dependent fibronectin assembly
Youmna Attieh et al.
JOURNAL OF CELL BIOLOGY (2017)
Dual role of pericyte α6β1-integrin in tumour blood vessels
Louise E. Reynolds et al.
JOURNAL OF CELL SCIENCE (2017)
Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses
Byron H. Kwan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
The opposing roles of laminin-binding integrins in cancer
Veronika Ramovs et al.
MATRIX BIOLOGY (2017)
Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression
P. A. Guerrero et al.
ONCOGENE (2017)
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer
Arman Jahangiri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells
Brian Bierie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Head and neck cancer cell radiosensitization upon dual targeting of c-Abl and beta1-integrin
Philipp Koppenhagen et al.
RADIOTHERAPY AND ONCOLOGY (2017)
The Role of Integrin α6 (CD49f) in Stem Cells: More than a Conserved Biomarker
Paul H. Krebsbach et al.
STEM CELLS AND DEVELOPMENT (2017)
The Use of PET Imaging for Prognostic Integrin α2β1 Phenotyping to Detect Non-Small Cell Lung Cancer and Monitor Drug Resistance Responses
Chiun-Wei Huang et al.
THERANOSTICS (2017)
Integrins and Exosomes, a Dangerous Liaison in Cancer Progression
Mayra Paolillo et al.
CANCERS (2017)
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma
Tobias L. Haas et al.
CELL STEM CELL (2017)
Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer
Ariella B. Hanker et al.
CANCER RESEARCH (2017)
A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors
Tufia Haddad et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
The complexity of integrins in cancer and new scopes for therapeutic targeting
Hellyeh Hamidi et al.
BRITISH JOURNAL OF CANCER (2016)
AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity
Eileen Brantley et al.
CANCER LETTERS (2016)
α3β1 Integrin Suppresses Prostate Cancer Metastasis via Regulation of the Hippo Pathway
Afshin Varzavand et al.
CANCER RESEARCH (2016)
Differential Effect on Bone Lesions of Targeting Integrins: Randomized Phase II Trial of Abituzumab in Patients with Metastatic Castration-Resistant Prostate Cancer
Maha Hussain et al.
CLINICAL CANCER RESEARCH (2016)
RGD-K5 PET/CT in patients with advanced head and neck cancer treated with concurrent chemoradiotherapy: Results from a pilot study
Shih-Hsin Chen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Hepatic Stellate Cells Induce Hepatocellular Carcinoma Cell Resistance to Sorafenib Through the Laminin-332/α3 Integrin Axis Recovery of Focal Adhesion Kinase Ubiquitination
Amalia Azzariti et al.
HEPATOLOGY (2016)
ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models
Danielle L. Peacock Brooks et al.
MOLECULAR CANCER (2016)
Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma
Xiao-Yan Ming et al.
NATURE COMMUNICATIONS (2016)
Enhanced Anti-Tumor Efficacy through a Combination of Integrin alpha v beta 6-Targeted Photodynamic Therapy and Immune Checkpoint Inhibition
Liquan Gao et al.
THERANOSTICS (2016)
Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
J. Vansteenkiste et al.
ANNALS OF ONCOLOGY (2015)
Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway
Nan Shao et al.
CANCER LETTERS (2015)
On the move: endocytic trafficking in cell migration
Tanja Maritzen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Epithelial polarity - Generating and integrating signals from the ECM with integrins
Aki Manninen
EXPERIMENTAL CELL RESEARCH (2015)
A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells
Cheng Chang et al.
GENES & DEVELOPMENT (2015)
α5β1 integrin recycling promotes Arp2/3-independent cancer cell invasion via the formin FHOD3
Nikki R. Paul et al.
JOURNAL OF CELL BIOLOGY (2015)
Integrin traffic - the update
Nicola De Franceschi et al.
JOURNAL OF CELL SCIENCE (2015)
Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer
Iris Eke et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino et al.
NATURE (2015)
A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity
Bartlomiej Waclaw et al.
NATURE (2015)
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma
Elizabeth R. Gerstner et al.
NEURO-ONCOLOGY (2015)
Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study
L. Burt Nabors et al.
NEURO-ONCOLOGY (2015)
Alpha2beta1 integrin in cancer development and chemoresistance
Dalila Naci et al.
SEMINARS IN CANCER BIOLOGY (2015)
Focal adhesion signaling and therapy resistance in cancer
Iris Eke et al.
SEMINARS IN CANCER BIOLOGY (2015)
Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
Laetitia Seguin et al.
TRENDS IN CELL BIOLOGY (2015)
Tissue Stiffness Dictates Development, Homeostasis, and Disease Progression
Andrew M. Handorf et al.
ORGANOGENESIS (2015)
Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer
Iris Eke et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial
E. ELez et al.
ANNALS OF ONCOLOGY (2015)
Integrins αvβ3 and αvβ5 as prognostic, diagnostic, and therapeutic targets in gastric cancer
Christine Boeger et al.
GASTRIC CANCER (2015)
Sorafenib resistance and JNK signaling in carcinoma during extracellular matrix stiffening
Thuy V. Nguyen et al.
BIOMATERIALS (2014)
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Nicola Aceto et al.
CELL (2014)
A Multicenter Phase 1 Study of EMD 525797 (DI17E6), a Novel Humanized Monoclonal Antibody Targeting αv Integrins, in Progressive Castration-resistant Prostate Cancer with Bone Metastases After Chemotherapy
Manfred Wirth et al.
EUROPEAN UROLOGY (2014)
Tumor-α9β1 integrin-mediated signaling induces breast cancer growth and lymphatic metastasis via the recruitment of cancer-associated fibroblasts
Daichi Ota et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp et al.
LANCET ONCOLOGY (2014)
An integrin β3-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition
Laetitia Seguin et al.
NATURE CELL BIOLOGY (2014)
Vitronectin-αvβ3 Integrin Engagement Directs Hypoxia-Resistant mTOR Activity and Sustained Protein Synthesis Linked to Invasion by Breast Cancer Cells
Carolina Pola et al.
CANCER RESEARCH (2013)
CD49f-positive cell population efficiently enriches colon cancer-initiating cells
Naotsugu Haraguchi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy
Iris Eke et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
β3 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells
David A. Tumbarello et al.
MOLECULAR CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling
Markus Schober et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells
Yu-Xia Chen et al.
ENDOCRINE-RELATED CANCER (2010)
The final steps of integrin activation: the end game
Sanford J. Shattil et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Mutant p53 Drives Invasion by Promoting Integrin Recycling
Patricia A. J. Muller et al.
CELL (2009)
Share Paper
